PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
Abstract: the pharmacoeconomic study compared the standard drug therapy (vitamin D and phosphorbinders) of secondary hyperparathyroidism (SHPT) to the using a combination of Mimpara (Cinalcet), vitamin D and phosphorbinders in patients with end-stage renal disease on dialysis. Comparison was carried...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
IRBIS LLC
2015-03-01
|
| Seri Bilgileri: | Фармакоэкономика |
| Konular: | |
| Online Erişim: | https://www.pharmacoeconomics.ru/jour/article/view/39 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|